Real‐world versus trial patients with transthyretin amyloid cardiomyopathy-Reference-Cited by-同舟云学术

Real‐world versus trial patients with transthyretin amyloid cardiomyopathy

Published:2019-07-24 Issue:11 Volume:21 Page:1479-1481
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Canepa Marco¹²,Tini Giacomo¹²,Musumeci Beatrice³,Cappelli Francesco⁴,Milandri Agnese⁵,Mussinelli Roberta⁶,Autore Camillo³,Perfetto Federico⁴,Rapezzi Claudio⁵,Perlini Stefano⁶

Affiliation:

1. Cardiovascular Disease UnitIRCCS Ospedale Policlinico San Martino – IRCCS Italian Cardiovascular Network Genova Italy

2. Department of Internal MedicineUniversity of Genova Genova Italy

3. Cardiology Unit, Clinical and Molecular Medicine Department, Faculty of Medicine and PsychologySapienza University of Rome Rome Italy

4. Tuscan Regional Amyloid CenterCareggi University Hospital Florence Italy

5. Cardiology, Department of Experimental, Diagnostic and Specialty MedicineAlma Mater University of Bologna Bologna Italy

6. Emergency Medicine, Department of Internal Medicine, Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San MatteoUniversity of Pavia Pavia Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1563

Reference7 articles.

1. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

2. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

3. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

4. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

5. Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of beta‐blockade on mortality in patients with cardiac amyloidosis: A systematic review and meta‐analysis;ESC Heart Failure;2024-07-23

2. Transthyretin amyloid cardiomyopathy in France: A cross-sectional multi-centre study (333 patients);Rare;2024

3. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study;European Journal of Internal Medicine;2023-10

4. Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy;International Journal of Molecular Sciences;2022-12-18

5. Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy;Frontiers in Cardiovascular Medicine;2022-07-11